Advertisement

Rheumaderm pp 23-26 | Cite as

Neonatal Lupus Erythematosus

  • B. R. Krafchik
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)

Abstract

Neonatal lupus is categorized by typical clinical features and the presence of maternal auto-antibodies. Mothers are uncommonly affected with clinical disease. The major clinical manifestations in neonates are cardiac, dermatological and hepatic, with rare instances of haemolytic anaemia and thrombocytopenia. The major morbidity and mortality result from complete congenital heart block. Dermatological manifestations occur mainly over the face and present with plaques of erythema with central atrophy, a mid-facial erythema, atrophy around the eyes and a telangiectatic variety. The long term outcome is usually excellent.

Keywords

Systemic Lupus Erythematosus Patent Ductus Arteriosus Complete Heart Block Cutaneous Lupus Erythematosus Congenital Heart Block 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aylward RD. Congenital Heart Block. Br Med J. 1: 943. (1928)Google Scholar
  2. 2.
    McCuiston CH, Schoch ER Possible discoid lupus erythematosus in newborn infant: Report of a case with subsequent development of acute systemic lupus erythematosus in the mother. Arch Dermat. 28: 782–785 (1954).CrossRefGoogle Scholar
  3. 3.
    Hogg Gr. Congenital acute lupus erythematosus associated with subendocardial fibroelastosis: report of a case. Am J Clin Path. 28: 648–654. (1957).PubMedGoogle Scholar
  4. 4.
    Franco HL, Weston WL, Tan EM, Peebles C, Forstot SL, Kohler PF. Association of antibodies to sicca syndrome antigen in newborns with lupus erythematosus and their mothers. Clin Res 28: 134A(1980). (Abstract).Google Scholar
  5. 5.
    Weston WL, Harmon C, Peebles C, et al. A serological marker for neonatal lupus erythematosus. Br J Dermatol 107(4): 377–382(1982).PubMedCrossRefGoogle Scholar
  6. 6.
    Lee LA, Weston WL. Special considerations concerning the cutaneous manifestations of rheumatic diseases in children. In: Sontheimer RD, Provost TT. (Eds): Cutaneous Manifestations of Rheumatic Diseases. Baltimore: Williams and Wilkins. Pp 323–344. (1995).Google Scholar
  7. 7.
    Kitridou RC, Minta G. The neonatal lupus syndrome. In: Wallace DJ, Hahn BH (Eds).Dubois’ Lupus Erythematosus. 4th Edition. Philadelphia: Lea and Febiger. Pp. 516–522. (1993).Google Scholar
  8. 8.
    Ramsay-Goldman R, Horn D, Deng JS, et al. Anti SS-A antibodies and foetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 29: 1269–1273 (1986).CrossRefGoogle Scholar
  9. 9.
    McCune AB, Weston WL, Lee LA. Maternal and foetal outcome in neonatal lupus erythematosus. Ann Int Med 106(4): 518–523(1987).PubMedGoogle Scholar
  10. 10.
    Thornton CM, Eichenfield LF, Shinall EA et al. Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol. 33: 19–25 (1995).PubMedCrossRefGoogle Scholar
  11. 11.
    Gochbereg SH: Congenital hear block. Am J Obstet Gynaecol. 88: 238–241 (1964).Google Scholar
  12. 12.
    Laxer RM, Roberts E, Gross KR et al. Liver disease in neonatal lupus erythematosus. J Pediatr. 116: 238–242(1990).PubMedCrossRefGoogle Scholar
  13. 13.
    Lee LA, Reichlin M, Ruyle SZ, Weston WL. Neonatal lupus liver disease. Lupus. 2: 333–338 (1993).PubMedCrossRefGoogle Scholar
  14. 14.
    Provost TT, Watson R, Gammon WR, Radowksy M, Harley JB, Reichlin M: The neonatal lupus syndrome associated with U1 RNP (nRNP) antibodies. New Eng J Med. 316(18): 1135–1138 (1987).PubMedCrossRefGoogle Scholar
  15. 15.
    Silverman ED, Buyon J, Laxer RM, et al. Auto-antibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol. 100: 499–505 (1995).PubMedCrossRefGoogle Scholar
  16. 16.
    Lee LA. Maternal autoantibodies and pregnancy: The neonatal lupus syndrome. Baillere’s Clin Rheumatol. 4(1): 69–84(1990).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • B. R. Krafchik
    • 1
  1. 1.Department of DermatologyHospital for Sick ChildrenTorontoCanada

Personalised recommendations